These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
651 related articles for article (PubMed ID: 18266020)
1. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Kanis JA; Burlet N; Cooper C; Delmas PD; Reginster JY; Borgstrom F; Rizzoli R; Osteoporos Int; 2008 Apr; 19(4):399-428. PubMed ID: 18266020 [TBL] [Abstract][Full Text] [Related]
2. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Kanis JA; McCloskey EV; Johansson H; Cooper C; Rizzoli R; Reginster JY; Osteoporos Int; 2013 Jan; 24(1):23-57. PubMed ID: 23079689 [TBL] [Abstract][Full Text] [Related]
3. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Kanis JA; Cooper C; Rizzoli R; Reginster JY; Osteoporos Int; 2019 Jan; 30(1):3-44. PubMed ID: 30324412 [TBL] [Abstract][Full Text] [Related]
4. Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Kanis JA; Cooper C; Rizzoli R; Reginster JY; Aging Clin Exp Res; 2019 Jan; 31(1):15-17. PubMed ID: 30612282 [TBL] [Abstract][Full Text] [Related]
6. Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Kanis JA; Cooper C; Rizzoli R; Reginster JY; Calcif Tissue Int; 2019 Mar; 104(3):235-238. PubMed ID: 30796490 [TBL] [Abstract][Full Text] [Related]
7. European guidance for the diagnosis and management of osteoporosis in postmenopausal women--what is the current message for clinical practice? Kanis JA; Reginster JY Pol Arch Med Wewn; 2008 Oct; 118(10):538-40. PubMed ID: 19112812 [No Abstract] [Full Text] [Related]
8. Bone mineral density and fractures in Turner syndrome. Bakalov VK; Chen ML; Baron J; Hanton LB; Reynolds JC; Stratakis CA; Axelrod LE; Bondy CA Am J Med; 2003 Sep; 115(4):259-64. PubMed ID: 12967689 [TBL] [Abstract][Full Text] [Related]
9. ["European Guidance 2008" for the diagnosis and management of postmenopausal osteoporosis--what is new and clinically relevant?]. Bartl R; Dtsch Med Wochenschr; 2009 Jan; 134(3):92-4. PubMed ID: 19142840 [No Abstract] [Full Text] [Related]
10. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Siris ES; Adler R; Bilezikian J; Bolognese M; Dawson-Hughes B; Favus MJ; Harris ST; Jan de Beur SM; Khosla S; Lane NE; Lindsay R; Nana AD; Orwoll ES; Saag K; Silverman S; Watts NB Osteoporos Int; 2014 May; 25(5):1439-43. PubMed ID: 24577348 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of a tool for identifying women with low bone mineral density and low-impact fractures: the São Paulo Osteoporosis Risk Index (SAPORI). Pinheiro MM; Reis Neto ET; Machado FS; Omura F; Szejnfeld J; Szejnfeld VL Osteoporos Int; 2012 Apr; 23(4):1371-9. PubMed ID: 21769663 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women. Mueller D; Gandjour A Value Health; 2009; 12(8):1106-17. PubMed ID: 19706151 [TBL] [Abstract][Full Text] [Related]
14. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A; Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937 [TBL] [Abstract][Full Text] [Related]
15. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Kanis JA; Harvey NC; McCloskey E; Bruyère O; Veronese N; Lorentzon M; Cooper C; Rizzoli R; Adib G; Al-Daghri N; Campusano C; Chandran M; Dawson-Hughes B; Javaid K; Jiwa F; Johansson H; Lee JK; Liu E; Messina D; Mkinsi O; Pinto D; Prieto-Alhambra D; Saag K; Xia W; Zakraoui L; Reginster J- Osteoporos Int; 2020 Jan; 31(1):1-12. PubMed ID: 31720707 [TBL] [Abstract][Full Text] [Related]
16. Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension. Miyauchi A; Dinavahi RV; Crittenden DB; Yang W; Maddox JC; Hamaya E; Nakamura Y; Libanati C; Grauer A; Shimauchi J Arch Osteoporos; 2019 Jun; 14(1):59. PubMed ID: 31168657 [TBL] [Abstract][Full Text] [Related]
17. Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Cooper C; Jakob F; Chinn C; Martin-Mola E; Fardellone P; Adami S; Thalassinos NC; Melo-Gomes J; Torgerson D; Gibson A; Marin F Osteoporos Int; 2008 Apr; 19(4):493-501. PubMed ID: 17968611 [TBL] [Abstract][Full Text] [Related]
18. A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial. Cranney A; Lam M; Ruhland L; Brison R; Godwin M; Harrison MM; Harrison MB; Anastassiades T; Grimshaw JM; Graham ID Osteoporos Int; 2008 Dec; 19(12):1733-40. PubMed ID: 18629567 [TBL] [Abstract][Full Text] [Related]
19. Practical issues in bone mineral density testing. Simonelli C J Am Med Womens Assoc (1972); 2000; 55(4):228-33. PubMed ID: 10935358 [TBL] [Abstract][Full Text] [Related]
20. The importance of morphometric radiographic vertebral assessment for the detection of patients who need pharmacological treatment of osteoporosis among postmenopausal diabetic Korean women. Choi YJ; Yang SO; Shin CS; Chung YS Osteoporos Int; 2012 Aug; 23(8):2099-2105. PubMed ID: 21975560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]